APA (7th ed.) Citation

Nathan, P., Hassel, J. C., Rutkowski, P., Baurain, J., Butler, M. O., Schlaak, M., . . . Piperno-Neumann, S. Overall survival benefit with tebentafusp in metastatic uveal melanoma. The New England journal of medicine, 385(13), . https://doi.org/10.1056/NEJMoa2103485

Chicago Style (17th ed.) Citation

Nathan, Paul, et al. "Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma." The New England Journal of Medicine 385, no. 13 (). https://doi.org/10.1056/NEJMoa2103485.

MLA (9th ed.) Citation

Nathan, Paul, et al. "Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma." The New England Journal of Medicine, vol. 385, no. 13, , https://doi.org/10.1056/NEJMoa2103485.